# Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery

> **NCT01923506** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 26 (actual)

## Conditions studied

- Recurrent Prostate Cancer
- Stage I Prostate Cancer
- Stage IIA Prostate Cancer
- Stage IIB Prostate Cancer
- Stage III Prostate Cancer

## Interventions

- **RADIATION:** stereotactic body radiation therapy
- **PROCEDURE:** quality-of-life assessment
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01923506
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-11-25
- **Primary completion:** 2026-07-28
- **Final completion:** 2026-07-28
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01923506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01923506, "Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01923506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*